News | News By Subject | News by Disease News By Date | Search News

Asthma News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Breath Therapeutics Holding BV Spins Out of PARI Pharma With $46 Million and a Ready-to-Go Phase III Drug/Device Combo     3/9/2017
Synairgen (SNG.L) Stock Tanks After Partner AstraZeneca PLC (AZN) Halts Asthma Drug Trial     10/12/2016
AstraZeneca PLC (AZN)'s Asthma Candidate Does Well in Final Late-Stage Test     9/6/2016
AstraZeneca PLC (AZN)'s Long-Acting Asthma Drug Symbicort Safe in Two Trials     9/1/2016
Vectura (VEC.L)'s Asthma Med Flutiform Flunks Final Late-Stage Study     8/30/2016
AstraZeneca PLC (AZN) Announces Positive Top-Line Data From Two Phase III SYMBICORT Studies     8/10/2016
Novartis AG (NVS)'s New Asthma Drug Hailed a Game-Changer After Success in Small Trial     8/9/2016
GlaxoSmithKline (GSK) Bets $230 Million on Johnson & Johnson (JNJ)'s Asthma Drug     7/27/2016
FDA Green Lights Genentech (RHHBY)'s Xolair for Allergic Asthma in Kids     7/11/2016
AstraZeneca PLC (AZN)'s Asthma Drug Hits Phase III Goal, Predicted to Reach Market in 2017     5/18/2016
Sorrento (SRNE) Reports Positive Data from Combined Phase II & III Clinical Study Of STI-004     5/16/2016
AstraZeneca PLC (AZN) Snaps Up All Rights to Orexo (ORXOF)'s OX-CLI Project     3/17/2016
AbbVie (ABBV) Coughs Up $595 Million+ for Boehringer Ingelheim's Psoriasis and Crohn’s Drugs     3/8/2016
Amid Fierce Competition from GlaxoSmithKline (GSK), AstraZeneca PLC (AZN) and Teva (TEVA), Two of Genentech (RHHBY)'s Asthma Drug Trials Disappoint     3/1/2016
FDA Green Lights GlaxoSmithKline (GSK)'s Nucala for Severe Asthma     11/5/2015

News from Around the Web
GlaxoSmithKline (GSK) Is Voluntarily Recalling 593,000 Ventolin Asthma Inhalers     4/5/2017
How Researchers Used A Smartphone To Study Asthma, Nature Biotechnology Reveals     3/15/2017
Danish Study Links Fish Oil During Pregnancy With Lower Asthma Risk In Kids, University of Copenhagen Reveals     12/29/2016
Wireless Connected Metered Dose Inhaler Tracks Medication Compliance, H&T Presspart Reveals     12/15/2016
How To Turn A Smartphone Into An Asthma Device     12/7/2016
Australian Asthma Storm Claims Sixth Victim     11/28/2016
Fighting For The Next Asthma Blockbuster: Italy Gets In The Way Of Novartis AG (NVS)     11/22/2016
Wearable Device Could Help Prevent Asthma Attacks, Quvium Reveals     9/28/2016
New Drug Shows Capability To Help People With Severe Asthma, Wake Forest University Baptist Medical Center Study     9/13/2016
Vitamin D May Help Reduce Asthma Attacks, Cochrane Review Finds     9/6/2016
NC State Research Center Develops Asthma Detection Technology     7/21/2016
New Devices, Wearable System Aim To Predict, Prevent Asthma Attacks, North Carolina State University Study     6/2/2016
3M Drug Delivery Systems Designs An "Intelligent Inhaler" System For COPD, Asthma And Other Respiratory Ills     4/26/2016
Women Smokers And Drinkers With Unhealthy BMIs At Two-Fold Higher Risk Of Asthma, St. Michael's Hospital Study Reveals     4/7/2016
Moms Who Eat Oily Fish During Pregnancy May Reduce Asthma Risk In Kids, University of Southampton Study     4/7/2016

Press Releases
GlaxoSmithKline (GSK) Submits EU Filing For Extended Use Of Relvar Ellipta In Patients With Controlled Asthma On An ICS/LABA Combination     7/21/2017
Teva (TEVA) Release: NICE Recommends CINQAERO (Reslizumab) For The Treatment Of Severe Eosinophilic Asthma     7/20/2017
ALK - Five-year GRAZAX Asthma Prevention (GAP) Trial Reveals Benefits Of Early Treatment Intervention In Children     7/7/2017
ALK: Five-year GRAZAX Asthma Prevention (GAP) Trial Reveals Benefits Of Early Treatment Intervention In Children     7/5/2017
Cannabis Science Invests In The Research And Development Of Cannabinoid-Based Medications To Treat COPD And Asthma     6/27/2017
Novartis AG (NVS): New Patient Survey Highlights Need For More Action To Help Severe Asthma Patients Gain Control Of Their Disease     6/19/2017
Xencor Presents Interim Data From An Ongoing, Open-Label, Phase II Study of XmAb5871 In Igg4-Related Disease At EULAR 2017     6/16/2017
AstraZeneca PLC (AZN) Release: Phase III ZONDA Trial For Benralizumab Shows Ability To Reduce Oral Steroid Use In Severe Asthma Patients     5/23/2017
Boehringer Ingelheim Release: American Thoracic Society 2017 Spiriva Respimat Improves Breathing For People With Asthma Regardless Of BMI Or Allergic Status     5/23/2017
AstraZeneca PLC (AZN)'s Asthma Drug Fails to Meet Primary Endpoint in Late-Stage Trial     5/10/2017
GlaxoSmithKline (GSK) Release: Relvar Ellipta Significantly Improved Asthma Control In Salford Lung Study Patients Compared With Their Usual Care     5/5/2017
Cincinnati Children's Hospital Medical Center Release: Experimental Drug Targets Nucleus Of Allergen-Sensitized Cells     4/19/2017
How Researchers Used A Smartphone To Study Asthma, Nature Biotechnology Reveals     3/15/2017
Rho Supports Manuscript Establishing Key Metrics For The Composite Asthma Severity Index     3/7/2017
GlaxoSmithKline (GSK)'s MUSCA Study Shows Nucala (Mepolizumab) Significantly Improves Quality Of Life And Lung Function In Severe Asthma Patients With An Eosinophilic Phenotype     3/6/2017

//-->